A Doctor's note on Coronavirus

f t # e
Washington, December 17, 2020 | comments

December 17, 2020

Dear Friends,

Moderna's COVID-19 vaccine candidate is set up to receive emergency use authorization tomorrow after an independent advisory committee of the Food and Drug Administration recommended authorization.

The Centers for Disease Control and Preventions will award $140 million for COVID-19 vaccine preparedness and almost $87 million for tracking and testing to 64 jurisdictions, including all 50 states and U.S. territories.

  • The CDC updated  guidanceon travel and ways to safely celebrate the winter holidays.

The Health Resources and Services Administration will distribute $24.5 billion to over 70,000 providers as part of Phase 3 of the Provider Relief Fund program. The Food and Drug Administration issued a new emergency use authorization for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for prescription use at home by patients with self-collected nasal swab samples.

The U.S. Department of Health and Human Services and the Department of Defense have invested in a phase 2 clinical trial that rapidly screens multiple potential COVID-19 treatments simultaneously through a platform clinical trial conducted by a non-profit research organization, Quantum Leap Research Collaborative of San Francisco.

National Institutes of Health Director Dr. Francis Collins wrote about COVID-19 in lung cells.

Until next time, this is your doctor's note.

Congressman Michael C. Burgess, M.D.

f t # e